All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @torylemoine on TikTok · 82s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @torylemoine's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00I'm going to use my vial as an example.
  2. 0:02Now I have to note that I'm not a doctor.
  3. 0:04I'm not a nurse.
  4. 0:05But just to use mine as kind of a guide, let me show you.
  5. 0:09And if you do have any questions about anything
  6. 0:12with Ambo as far as like injections and dosing,
  7. 0:14always ask your doctor.
  8. 0:16But just for an example, mine is the four milligram.
  9. 0:19I think someone had asked me this
  10. 0:20and I said it was the one milligram I was mistaken.
  11. 0:23It says it's the four milligram,
  12. 0:25but that is completely irrelevant
  13. 0:27to how you will be administering your medicine.
  14. 0:29Because no matter what the dosing is,
  15. 0:31this is going to be what matters.
  16. 0:32Inject .25 mLs or 25 units under the skin.
  17. 0:38This right here is what you're injecting.
  18. 0:41This is just your strength.
  19. 0:43And then that's how much B12 is in it.
  20. 0:45If you have your syringe, it has the numbers on it.
  21. 0:48Very easy to understand.
  22. 0:50So you see there's the 25.
  23. 0:51So you will pull it up to that 25 mark.
  24. 0:55Now I've shown this before,
  25. 0:56but whenever I'm injecting anything,
  26. 0:58I pull it up past the point
  27. 1:00because you're going to have a little air bubble at the top.
  28. 1:02So you're going to pull it up past the 25 in my case.
  29. 1:05Yours is going to be different or maybe it's the same,
  30. 1:07but go by yours.
  31. 1:08So you'll pull it up past that.
  32. 1:10And then I just kind of flick it
  33. 1:11before I push it back into the vial
  34. 1:13to get that air bubble out.
  35. 1:15And then line the plunger up with the number
  36. 1:17that it says on your vial.
  37. 1:20But yeah, hope that helps.

@torylemoine's GLP-1 dosing explained, fact-checked

Tory Lemoine

TikTok creator

19.2K viewsWatch on TikTok

Quick answer

The video demonstrates subcutaneous injection technique for a compounded GLP-1 medication, specifically addressing how to reconcile vial concentration labeling with syringe volume markings on a U-100 insulin syringe. The creator confirms their prescribed draw volume is 0.25 mL (25 units on a U-100 syringe) from a 4 mg/mL compounded vial, which is consistent with common starting doses in supervised GLP-1 weight management programs. The content is explicitly sponsored by a telehealth platform and should be evaluated in that commercial context.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @torylemoine's GLP-1 dosing explained, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@torylemoine's GLP-1 dosing explained, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@torylemoine's GLP-1 dosing explained, fact-checked" from Tory Lemoine. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video demonstrates subcutaneous injection technique for a compounded GLP-1 medication, specifically addressing how to reconcile vial concentration labeling with syringe volume markings on a U-100 insulin syringe.

The reason this review is not generic is the source wording and the canonical claim label "trt replying to pam k w administering glp1 what do all these n." In this clip, the useful excerpt is: "I'm going to use my vial as an example." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The FDA issued a 2023 safety alert specifically about compounded semaglutide dosing errors tied to patients misreading concentration labels and confusing units with mLs.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The video demonstrates subcutaneous injection technique for a compounded GLP-1 medication, specifically addressing how to reconcile vial concentration labeling with syringe volume markings on a U-100 insulin syringe.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video demonstrates subcutaneous injection technique for a compounded GLP-1 medication, specifically addressing how to reconcile vial concentration labeling with syringe volume markings on a U-100 insulin syringe. The creator confirms their prescribed draw volume is 0.25 mL (25 units on a U-100 syringe) from a 4 mg/mL compounded vial, which is consistent with common starting doses in supervised GLP-1 weight management programs. The content is explicitly sponsored by a telehealth platform and should be evaluated in that commercial context.
  • On a U-100 insulin syringe (the standard home-use type), 25 units equals exactly 0.25 mL. This conversion drives almost all at-home GLP-1 dosing math.
  • The FDA issued a 2023 safety alert specifically about compounded semaglutide dosing errors tied to patients misreading concentration labels and confusing units with mLs.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • On a U-100 insulin syringe (the standard home-use type), 25 units equals exactly 0.25 mL. This conversion drives almost all at-home GLP-1 dosing math.
  • The FDA issued a 2023 safety alert specifically about compounded semaglutide dosing errors tied to patients misreading concentration labels and confusing units with mLs.
  • A 4 mg/mL vial and a 1 mg/mL vial of the same compound require four times the draw volume to deliver the same dose. Assuming another person's draw volume is dangerous.
  • Compounded GLP-1 medications are not FDA-approved and are not equivalent to branded Ozempic, Wegovy, or Mounjaro. Potency and sterility standards vary by compounding pharmacy.
  • The creator's air-bubble technique is functionally acceptable but imprecise for beginners. Clinical guidance recommends expelling bubbles before removing the needle from the vial.
  • Any injection tutorial from a sponsored social media creator is a commercial product, not medical instruction. Your prescribing clinician's written instructions take precedence over any video.
  • The creator's prior on-camera error (calling a 4 mg/mL vial '1 mg/mL') is a real-world example of why concentration literacy matters. A fourfold error in concentration assumption could result in a fourfold overdose.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @torylemoine actually say?

The creator walked through how to read a GLP-1 compounded vial, explaining that the concentration printed on the label (in their case, "four milligram") is separate from the injection volume instruction. Their core message: "this is going to be what matters," pointing to the prescribed volume in mLs and its syringe equivalent in units. They also demonstrated pulling the plunger slightly past the target mark to account for an air bubble, then flicking and pushing back to clear it before landing on the correct line.

They were upfront about not being a medical professional and repeatedly directed viewers to consult their own prescribing doctor. That disclaimer matters, because this video is explicitly tagged as an ad for Amble, a telehealth platform, and reached nearly 20,000 viewers who may be self-injecting at home.

Does the science back this up?

The core claim, that mL volume is what you draw regardless of concentration, is pharmacologically correct. Compounded GLP-1 formulations, typically semaglutide or tirzepatide, vary widely in concentration between compounding pharmacies. A 4 mg/mL vial and a 1 mg/mL vial require very different draw volumes to deliver the same dose. The instruction on your specific vial label is the only reliable guide.

This confusion is not trivial. A 2023 FDA safety communication flagged multiple patient reports of dosing errors with compounded semaglutide, specifically because patients were converting between units and mLs incorrectly or misreading insulin syringe markings. U-100 insulin syringes, which most home injectors use, measure in units where 100 units equals 1 mL. So 25 units equals 0.25 mL, which matches what the creator demonstrated. That math checks out.

The air-bubble technique the creator describes is a reasonable lay approach, though clinical training typically teaches users to draw slightly over, flick, and expel the bubble before removing the needle from the vial rather than pushing medication back in. The net result is the same, but technique details matter when you are learning from a social media video rather than a nurse.

What did they get wrong (or right)?

Credit where it is due: the creator correctly identified that concentration on the vial label does not equal the dose you inject. That is probably the single most important thing a new self-injector needs to understand, and a lot of online content gets it wrong or ignores it entirely.

The earlier correction, admitting they previously told someone it was "the one milligram" when it was actually "the four milligram," is worth pausing on. That is a fourfold concentration difference. If someone had followed the wrong concentration assumption and tried to calculate their own draw volume, they could have injected four times their intended dose. The creator treats this correction as minor, but it illustrates exactly why concentration literacy matters.

The air-bubble technique is not wrong, but describing it as pulling "past the point" and then pushing back into the vial could confuse beginners about whether they are contaminating the vial or wasting medication. A cleaner explanation would help. No specific dosing recommendations were made beyond referencing their own prescription, which is appropriate.

What should you actually know?

If you are self-injecting a compounded GLP-1 at home, here is what actually matters. First, your vial label will show concentration, usually in mg/mL. Your prescription or clinical instructions will tell you the dose in mg. Those two numbers together determine your draw volume. Do not guess, and do not borrow someone else's draw volume because they are on "the same medication."

Second, most home injectors use U-100 insulin syringes. On those syringes, 1 unit equals 0.01 mL. So 25 units equals 0.25 mL. This is consistent with what the creator demonstrated. The FDA's 2023 alert specifically cited confusion between these units as a source of serious overdose events.

Third, compounded GLP-1 products are not the same as branded semaglutide or tirzepatide. They are not FDA-approved, and potency can vary by batch and compounder. Any injection tutorial, including this one, is a supplement to, not a replacement for, individualized instruction from your prescribing clinician.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Tory Lemoine · TikTok creator

19.2K views on this video

Replying to @pam_k_w Administering GLP1: What do all these numbers mean? #glp1 #glp1forweightloss #glp1medication #glp1community #joinamble #ambleptnr #ad @Join Amble #weightloss

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about on a u-100 insulin syringe (the standard home-use type), 25?

On a U-100 insulin syringe (the standard home-use type), 25 units equals exactly 0.25 mL. This conversion drives almost all at-home GLP-1 dosing math.

What does the video say about the fda?

The FDA issued a 2023 safety alert specifically about compounded semaglutide dosing errors tied to patients misreading concentration labels and confusing units with mLs.

What does the video say about a 4 mg/ml vial?

A 4 mg/mL vial and a 1 mg/mL vial of the same compound require four times the draw volume to deliver the same dose. Assuming another person's draw volume is dangerous.

What does the video say about compounded glp-1 medications?

Compounded GLP-1 medications are not FDA-approved and are not equivalent to branded Ozempic, Wegovy, or Mounjaro. Potency and sterility standards vary by compounding pharmacy.

What does the video say about the creator's air-bubble technique?

The creator's air-bubble technique is functionally acceptable but imprecise for beginners. Clinical guidance recommends expelling bubbles before removing the needle from the vial.

What does the video say about any injection tutorial from a sponsored social media creator?

Any injection tutorial from a sponsored social media creator is a commercial product, not medical instruction. Your prescribing clinician's written instructions take precedence over any video.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Tory Lemoine, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.